These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29192951)

  • 21. Sirolimus-eluting BiOSS LIM dedicated bifurcation stent in the treatment of unprotected distal left main stenosis.
    Briguori C; Visconti G; Golino M; Focaccio A; Signoriello G
    Catheter Cardiovasc Interv; 2019 Sep; 94(3):323-331. PubMed ID: 30773807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the Bifurcation Optimization Stent System in cardiological settings.
    Vassilev DI; Mileva NB; Gil RJ
    Future Cardiol; 2020 Sep; 16(5):397-404. PubMed ID: 32286883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Randomized, Multicenter, Open-Label, Controlled POLBOS 3 Trial Comparing Regular Drug-Eluting Stents and the Sirolimus-Eluting BiOSS LIM C Dedicated Coronary Bifurcation Stent: Four-Year Results.
    Gil RJ; Kern A; Bojko K; Gziut-Rudkowska A; Vassilev D; Bil J
    Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
    Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study.
    Verheye S; Agostoni P; Dubois CL; Dens J; Ormiston J; Worthley S; Trauthen B; Hasegawa T; Koo BK; Fitzgerald PJ; Mehran R; Lansky AJ
    J Am Coll Cardiol; 2009 Mar; 53(12):1031-9. PubMed ID: 19298915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of vascular response to BiOSS LIM C
    Bil J; Gil RJ; Pawlowski T; Milewski KP
    Cardiovasc Ther; 2017 Aug; 35(4):. PubMed ID: 28423237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.
    Park KW; Kang SH; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Hur SH; Ryu JK; Lee BR; Park YW; Chae IH; Kim HS;
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2805-16. PubMed ID: 24814486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dedicated Bifurcation Drug-eluting Stent BiOSS® - A Novel Device for Coronary Bifurcation Treatment.
    Gil RJ; Vassilev D; Bil J
    Interv Cardiol; 2013 Mar; 8(1):19-22. PubMed ID: 29588746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twelve-month clinical outcomes of "nano-crush technique" for the treatment of bifurcation lesions using ultra-thin (60 µm) sirolimus-eluting coronary stents.
    Sinha SK; Kumar P; Pandey U; Aggarwal P; Razi M; Sharma AK; Jha M; Sachan M; Shukla P; Thakur R; Krishna V; Mukherjee P; Karmakar S; Bhattacharjee P; Ray S
    Minerva Cardiol Angiol; 2023 Feb; 71(1):51-60. PubMed ID: 35212507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of a second-generation coronary sirolimus-eluting stent with biodegradable polymers in daily clinical practice: a 12-month follow-up of the ALEX registry.
    Hawranek M; Desperak P; Ciślak A; Gąsior P; Gierlotka M; Wąs T; Chodór P; Kowalczyk J; Lekston A; Gąsior M
    Coron Artery Dis; 2016 Mar; 27(2):89-94. PubMed ID: 26580300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial.
    van der Heijden LC; Kok MM; Lam MK; Danse PW; Schramm AR; Jessurun GA; Tjon Joe Gin RM; van Houwelingen KG; Hautvast RW; Linssen GC; Sen H; Löwik MM; IJzerman MJ; Doggen CJ; von Birgelen C
    Clin Res Cardiol; 2016 Mar; 105(3):206-15. PubMed ID: 26329584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of biodegradable polymer sirolimus-eluting PROLIM stent in patients with coronary artery disease. Results of 12-month follow-up of prospective registry.
    Roleder T; Smolka G; Podolecka E; Chudek J; Dworowy S; Żelazowska K; Wojakowski W; Ochała A
    Kardiol Pol; 2016; 74(5):411-7. PubMed ID: 26502940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis.
    Bil J; Gil RJ; Kern A; Pawłowski T; Seweryniak P; Śliwiński Z
    BMC Cardiovasc Disord; 2015 Nov; 15():150. PubMed ID: 26573577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).
    Ohya M; Kadota K; Toyofuku M; Morimoto T; Higami H; Fuku Y; Yamaji K; Muranishi H; Yamaji Y; Nishida K; Furukawa D; Tada T; Ko E; Ando K; Sakamoto H; Tamura T; Kawai K; Kimura T;
    Am J Cardiol; 2017 Feb; 119(3):355-364. PubMed ID: 27887688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
    Buszman PP; Orlik B; Trela B; Milewski K; Kozlowski M; Pruski M; Drzewiecki J; Peppas A; Granada JF; Kaluza GL; Buszman PE
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E155-62. PubMed ID: 23109067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
    Généreux P; Kumsars I; Lesiak M; Kini A; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB
    J Am Coll Cardiol; 2015 Feb; 65(6):533-43. PubMed ID: 25677311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of lumen enlargement mechanisms achieved with the bifurcation dedicated BiOSS) stent versus classical coronary stent implantations by means of provisional side branch stenting strategy: an intravascular ultrasound study.
    Gil RJ; Bil J; Michałek A; Vassiliev D; Costa RA
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1667-76. PubMed ID: 23868287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.